Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens | Oneindia News

Video Credit: Oneindia
Published on July 1, 2021 - Duration: 02:09s

Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens | Oneindia News

Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine ZyCov-D.

An approval for Zydus' vaccine, would make it the fifth vaccine authorized for use in India, after Moderna, AstraZeneca and partner Serum Institute of India's Covishield, Bharat Biotech's Covaxin, and Russi'as Sputnik V vaccine.

#ZydusCadila #ZyCovD #EUA

You are here

💡 newsR Knowledge: Other News Mentions

Cadila Healthcare

Indian multinational pharmaceutical company
On PM Narendra Modi's 71st birthday, India set a new record for single-day vaccinations and administered over 2 crore COVID-19 vaccine doses.
Credit: DNA - Published 6 days ago

Serum Institute of India

Indian biotechnology and biopharmaceuticals company
“Covishield is a licensed product of the UK company, manufactured in India of which we have supplied five million doses to the UK,” said Shringla, pointing..
Credit: IndiaTimes - Published 1 day ago

PM Narendra Modi, along with Mamata Banerjee and Adar Poonawala, has secured a place in TIME Magazine's '100 most influential people of 2021' list.
Credit: DNA - Published 1 week ago

Prime Minister Narendra Modi, West Bengal chief minister Mamata Banerjee and Serum Institute of India CEO Adar Poonawalla have been named among the world's 100..
Credit: IndiaTimes - Published 1 week ago

Oxford–AstraZeneca COVID-19 vaccine

Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca
The UK has revised its vaccine policy for travelers from India, and Covishield jabs have been approved in the travel advisory.
Credit: DNA - Published 17 hours ago

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Covaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr..
Credit: IndiaTimes - Published 2 days ago

SAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
Credit: DNA - Published 5 days ago


Vaccine against COVID-19
India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients..
Credit: DNA - Published 1 week ago

Related videos from verified sources

Needle-free Zydus Cadila vaccine: How does it work? | DNA vaccine explained | Oneindia News 02:06
Video credit: Oneindia - Published on July 1, 2021 

You might like